VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
STRRStar Equity Holdings, Inc.
$10.94$40M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSTRRFinancials

Star Equity Holdings, Inc. (STRR) Financials

24Y historyFree accessUpdated daily

Revenue volatility remains extreme, with quarterly figures swinging from $9.1M to $56.8M, while operating margins have failed to turn positive, settling at -8.0% in 2026Q1.

STRR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02
Sales/Revenue190.35M172.16M53.36M161.34M112.15M106.56M78.16M72.93M104.18M118.34M125.47M60.83M55.61M49.38M50.51M53.74M56.18M69.6M80.36M73.95M71.93M68.19M68.14M56.24M41.53M
Revenue Growth %139.76%222.64%-66.93%43.86%5.25%36.33%7.17%-29.99%-11.96%-5.68%106.27%9.38%12.62%-2.25%-6.01%-4.34%-19.27%-13.39%8.67%2.81%5.49%0.07%21.16%35.41%-
Cost of Goods Sold107.32M93.5M42.3M81.07M86.27M91.32M64.18M55.77M85.91M89.94M89.69M42.92M38.97M35.26M37.42M38.99M44.18M49.37M60.29M53.43M52.87M52.94M46.38M39.67M30.36M
COGS % of Revenue-54.31%79.28%50.25%76.92%85.7%82.11%76.47%82.46%76%71.49%70.56%70.08%71.41%74.08%72.54%78.63%70.94%75.02%72.25%73.5%77.64%68.07%70.54%73.09%
Gross Profit83.03M78.66M11.05M80.27M25.88M15.24M13.99M17.16M18.27M28.4M35.77M17.91M16.64M14.12M13.09M14.76M12M20.23M20.07M20.52M19.06M15.25M21.76M16.57M11.18M
Gross Margin %43.62%45.69%20.72%49.75%23.08%14.3%17.89%23.53%17.54%24%28.51%29.44%29.92%28.59%25.92%27.46%21.37%29.06%24.98%27.75%26.5%22.36%31.93%29.46%26.91%
Gross Profit Growth %-611.51%-86.23%210.16%69.81%8.96%-18.49%-6.08%-35.67%-20.6%99.75%7.63%17.88%7.82%-11.29%22.94%-40.65%0.77%-2.18%7.66%25.01%-29.93%31.33%48.24%-
Operating Expenses89.01M82.34M19.47M78.88M28.98M26.84M21.2M19.07M22.82M26.5M32.69M15.13M14.12M13.79M18.19M18.43M18.24M19.85M26.39M23.36M27.28M26.25M21.18M16.85M22.02M
OpEx % of Revenue-47.83%36.49%48.89%25.84%25.18%27.12%26.15%21.9%22.39%26.05%24.88%25.4%27.92%36.01%34.3%32.46%28.52%32.84%31.59%37.93%38.5%31.08%29.97%53.03%
Selling, General & Admin88.77M82.34M16.99M77.42M27.26M22.59M18.64M15.9M20.46M24.84M30.04M14.63M13.07M12.53M14.24M15.36M14.93M15.9M20.36M19.59M23.36M22.05M17.39M14.22M18.04M
SG&A % of Revenue-47.83%31.84%47.98%24.31%21.2%23.84%21.8%19.64%20.99%23.94%24.05%23.51%25.37%28.19%28.59%26.57%22.84%25.34%26.49%32.48%32.34%25.53%25.28%43.45%
Research & Development00000000000001.02M3.72M2.74M2.88M3.36M2.76M3.07M3.89M3.68M2.98M2.19M2.97M
R&D % of Revenue-------------2.08%7.36%5.09%5.12%4.83%3.44%4.15%5.41%5.4%4.38%3.9%7.14%
Other Operating Expenses245K02.48M1.47M1.72M4.24M2.56M3.17M2.36M3M4.51M506K1.05M231K233K331K435K590K3.26M697K27K520K800K443.78K1.01M
Operating Income-5.98M-3.69M-8.41M1.38M-3.1M-11.6M-7.21M-1.91M-4.54M-6.02M3.08M2.77M2.52M171K-5.1M-3.51M-6.59M58K-7.62M-2.84M-8.22M-11M582K-284.17K-10.85M
Operating Margin %-3.14%-2.14%-15.77%0.86%-2.77%-10.88%-9.22%-2.62%-4.36%-5.09%2.46%4.56%4.53%0.35%-10.09%-6.53%-11.73%0.08%-9.49%-3.84%-11.43%-16.14%0.85%-0.51%-26.12%
Operating Income Growth %-56.17%-708.46%144.54%73.22%-60.86%-277.58%58%24.49%-295.11%11.21%10.17%1372.51%103.35%-45.24%46.74%-11462.07%100.76%-168.36%65.45%25.26%-1990.55%304.81%97.38%-
EBITDA-4.48M-2.48M-4.81M2.85M430K-6.66M2.81M6.17M4.16M5.04M12.97M5.21M4.45M2.08M-2.97M-414K-2.34M5.24M-1.22M2.32M-3.5M-5.74M3.73M2.97M-6.9M
EBITDA Margin %-2.35%-1.44%-9.02%1.77%0.38%-6.25%3.59%8.45%4%4.26%10.34%8.57%8.01%4.22%-5.87%-0.77%-4.17%7.52%-1.51%3.14%-4.87%-8.42%5.48%5.28%-16.6%
EBITDA Growth %-312.25%48.56%-268.88%562.79%106.45%-337.37%-54.48%48.11%-17.48%-61.11%148.78%17.11%113.68%170.24%-616.67%82.31%-144.69%530.24%-152.37%166.38%39%-253.78%25.62%143.08%-
D&A (Non-Cash Add-back)1.5M1.21M3.6M1.47M3.54M4.93M10.02M8.07M8.71M11.06M9.89M2.44M1.94M1.91M2.13M3.1M4.25M5.18M6.41M5.17M4.72M5.26M3.15M3.25M3.95M
EBIT-5.85M-3.69M-8.41M1.38M-3.54M-7.97M-3.86M-2.19M-4.65M-6.32M5.28M2.54M3.21M331K-5M-3.24M-6.24M377K-6.83M-2.84M-8.22M-11M1.13M-284.17K-10.85M
Net Interest Income176K260K633K372K-564K-905K-1.29M-746K-751K-730K-1.41M-24K19K48K97K165K378K490K819K02.1M1.68M331K35.41K0
Interest Income189K260K633K372K0000000272K58K63K101K267K378K499K851K02.1M1.68M035.41K0
Interest Expense13K000564K905K1.29M746K751K730K1.41M296K39K15K4K009K32K000245K00
Other Income/Expense-212K-168K-1.76M1.19M-2.34M2.72M2.05M-1.03M-855K-1.03M-1.2M-257K19K48K174K168K376K550K759K1.47M1.93M1.38M-337K-1.4M-1.92M
Pretax Income-6.19M-3.86M-10.18M2.57M-5.44M-8.87M-5.16M-2.94M-5.4M-7.05M1.89M2.52M2.54M219K-4.92M-3.34M-6.21M608K-6.87M-1.38M-6.29M-9.62M245K-1.68M-12.77M
Pretax Margin %-3.25%-2.24%-19.07%1.59%-4.85%-8.33%-6.6%-4.03%-5.18%-5.96%1.5%4.14%4.56%0.44%-9.75%-6.22%-11.06%0.87%-8.54%-1.86%-8.75%-14.11%0.36%-2.99%-30.75%
Income Tax1.76M2.06M263K370K383K60K129K-199K-1.56M27.99M-12.42M-19.12M62K-45K000000000-1.68M-12.77M
Effective Tax Rate %-28.48%-53.45%-2.58%14.41%-7.04%-0.68%-2.5%6.77%28.91%-397.04%-658.73%-759.75%2.44%-20.55%0%0%0%0%0%0%0%0%0%100%100%
Net Income-7.95M-5.92M-10.44M2.2M-5.25M-2.98M-6.46M-4.63M736K-35.73M14.3M21.64M2.48M264K-4.92M-3.34M-6.21M608K-6.87M-1.38M-6.29M-9.62M245K-1.68M-12.77M
Net Margin %-4.18%-3.44%-19.56%1.36%-4.68%-2.8%-8.26%-6.34%0.71%-30.19%11.4%35.58%4.45%0.53%-9.75%-6.22%-11.06%0.87%-8.54%-1.86%-8.75%-14.11%0.36%-2.99%-30.75%
Net Income Growth %-31.6%43.31%-574.89%141.85%-76.06%53.8%-39.55%-728.67%102.06%-349.83%-33.91%774.34%837.5%105.36%-47.34%46.22%-1122.04%108.86%-398.91%78.12%34.61%-4026.12%114.58%86.84%-
Net Income (Continuing)-7.95M-5.92M-10.44M2.2M-5.83M-8.93M-5.29M-2.74M-3.84M-35.04M14.3M21.64M2.48M264K-4.92M-3.34M-6.21M608K-6.87M-1.38M-6.29M-9.62M245K00
Discontinued Operations0000575K5.95M-1.17M-1.89M4.58M0000000000000000
Minority Interest0000000000000000000000000
EPS (Diluted)-2.12-2.08-3.97-1.11-1.27-0.96-2.29-2.562.00-17.8735.5055.006.500.10-2.55-1.75-3.311.50-3.62-0.73-3.35-5.210.05-516.22-3923.73
EPS Growth %57.1%47.61%-257.66%12.6%-32.29%58.08%10.55%-228%111.19%-150.34%-35.45%746.15%6400%103.92%-45.71%47.13%-320.67%141.44%-395.89%78.21%35.7%-10625.25%100.01%86.84%-
EPS (Basic)--2.08-3.97-1.11-1.27-0.96-2.29-2.560.04-17.8736.5056.506.500.10-2.60-1.75-3.311.50-3.62-0.73-3.35-5.210.10-1069.58-3923.73
Diluted Shares Outstanding3.74M3.2M3.15M4.13M4.13M5.08M3.66M2.04M2.02M2M2.01M1.97M1.89M1.92M1.93M1.91M1.88M1.93M1.9M1.88M1.88M1.85M1.7M3.25K3.25K
Basic Shares Outstanding3.74M3.2M3.15M4.13M4.13M5.08M3.66M2.04M2.02M2M1.96M1.92M1.86M1.88M1.89M1.91M1.88M1.88M1.9M1.88M1.88M1.85M1.01M1.57K3.25K
Dividend Payout Ratio--------451.22%-27.36%17.71%150.02%350.38%-----------

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetAdequate
Cash FlowBurning
Top Statement Risk

Persistent Operating Margin Deficit

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Volatility Masks Structural Shifts

As reported in financial statements, STRR's revenue trajectory exhibits extreme volatility, with quarterly figures swinging from $9.1M to $56.8M over the last ten periods, reflecting the integration of disparate construction acquisitions that have fundamentally altered the company's top-line composition and obscured organic growth trends.

The massive revenue fluctuations suggest that the company is currently in a transition phase where inorganic growth from construction assets dominates the legacy diagnostic services business. Investors should monitor whether this growth is sustainable or merely a byproduct of aggressive acquisition-led scaling that lacks a cohesive organic core.

Gross Margin Expansion Faces Headwinds

According to recent SEC filings, STRR has seen gross margins fluctuate significantly, peaking at 52.4% in 2025Q2 before settling near 40.4% in 2026Q1, indicating that the company's ability to maintain pricing power is highly sensitive to the shifting mix between healthcare services and modular construction inputs.

The volatility in gross margins suggests that the company struggles to maintain consistent profitability across its bifurcated business model. The reliance on raw material inputs for construction likely introduces cyclical margin pressure that the more stable diagnostic services segment cannot fully offset during periods of high inflation.

Operating Leverage Remains Elusive

Based on STRR's reported figures, the company consistently fails to achieve positive operating income, with a -8.0% operating margin in 2026Q1, suggesting that corporate overhead and holding company expenses are currently scaling faster than the gross profit generated by its underlying healthcare and construction business units.

The inability to convert gross profit into operating income indicates a lack of operational efficiency at the holding company level. This suggests that the current organizational structure may be too heavy for the scale of the underlying operations, necessitating a more disciplined approach to managing SG&A expenses.

Conglomerate Complexity Risks Value Destruction

As evidenced by the persistent net losses and negative operating margins, the company's strategy of combining medical diagnostics with modular construction appears to create a conglomerate discount, as the disparate operational requirements likely distract management and prevent the realization of meaningful synergies across the two distinct segments.

Short-sellers would likely focus on the persistent cash burn and the lack of a clear path to profitability despite significant top-line growth. The company's history of net losses warrants further investigation into whether the holding company model is designed to create shareholder value or simply to utilize tax assets.

STRR — Frequently Asked Questions

Quick answers to the most common questions about buying STRR stock.

What was Star Equity Holdings, Inc.'s (STRR) revenue in 2025?

For fiscal year 2025, Star Equity Holdings, Inc. (STRR) reported total revenue of $172.2M. This represents a 314.5% increase compared to $41.5M in 2002.

Is Star Equity Holdings, Inc. (STRR) profitable?

Star Equity Holdings, Inc. (STRR) reported a net loss of $5.9M for the fiscal year ending 2025.

What is Star Equity Holdings, Inc.'s operating profit margin?

Star Equity Holdings, Inc. (STRR) reported an operating income of $-3.7M, resulting in an operating profit margin of -2.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Star Equity Holdings, Inc.'s gross profit and gross margin?

Star Equity Holdings, Inc. (STRR) generated $78.7M in gross profit for the year, representing a gross profit margin of 45.7%. This demonstrates the company's core pricing power and production efficiency.